Please assess the completion status of the following clinical trial:

Trial Title: Inhibition of Aldosterone in Patients With Chronic Renal Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Proteinuria \> 500 mg/24 hours~* Hypertension or anti-hypertensive treatment~Exclusion Criteria:~* Diabetic nephropathy~* GFR\< 20 ml/min~* P-potassium between 3,5 mmol/l and 5,0 mmol/l

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Eplerenone
- 2 (Type: NO_INTERVENTION): Control

Based on this trial design, predict the completion outcome and termination type (if applicable).